The clinical utility of aflibercept for diabetic macular edema

Michael W StewartDepartment of Ophthalmology, Mayo School of Medicine, Jacksonville, FL, USAAbstract: The treatment of center-involving diabetic macular edema (DME) has improved because of the proven efficacy of drugs that inhibit the effects of vascular endothelial growth factor (VEGF). The newest...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Stewart MW
Format: article
Langue:EN
Publié: Dove Medical Press 2015
Sujets:
Accès en ligne:https://doaj.org/article/858c1642809b40a2ac5ad0401170055d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!